Ads
related to: paid clinical trials multiple sclerosiswexnermedical.osu.edu has been visited by 10K+ users in the past month
262 Neil Avenue # 430, Columbus, Ohio · Directions · (614) 221-7464
- Symptom Management Clinic
Offering innovative ways
to manage your disease
- Wexner Medical Center
Learn more about
Wexner Medical Center
- MS Treatment
Learn about available
MS treatment options
- MS Symptoms
Learn more about the
most common MS symptoms
- Symptom Management Clinic
dvcstem.com has been visited by 100K+ users in the past month
Search results
Results from the WOW.Com Content Network
Research in multiple sclerosis may find new pathways to interact with the disease, improve function, curtail attacks, or limit the progression of the underlying disease. Many treatments already in clinical trials involve drugs that are used in other diseases or medications that have not been designed specifically for multiple sclerosis .
A small, short-duration clinical trial [103] with MS patients was conducted at the University of California, San Francisco. In October 2007 data was presented at the European Congress of MS in Prague regarding safety findings of a pilot study of low dose naltrexone therapy in multiple sclerosis by neurological researchers in Milan, Italy. [104]
Multiple sclerosis (MS) is an autoimmune disease resulting in damage to the insulating covers of nerve cells in the brain and spinal cord. [3] As a demyelinating disease, MS disrupts the nervous system's ability to transmit signals, resulting in a range of signs and symptoms, including physical, mental, and sometimes psychiatric problems.
The Multiple Sclerosis Functional Composite (MSFC) is a clinical trial outcome measure of assessing the severity of multiple sclerosis primarily used in research. [1] The score is based on a combination of timed tests of walking, arm function, and cognitive ability. [1]
The DRKS is an open access, free of charge online register for clinical trials and is available both in English and German. DRKS is part of the WHO's ICTRP. The DRKS works with two partner registries in Germany, DeReG (German Registry for Somatic Gene-Transfer Trials) and Clinical Trial Registry of the University Medical Center Freiburg. [4]
Natalizumab was originally approved for treatment of multiple sclerosis in 2004, through the FDA's accelerated Fast Track program, due to the drug's efficacy in one-year clinical trials. In February 2005, four months after its approval, natalizumab was withdrawn voluntarily by the manufacturer after two cases of progressive multifocal ...
Ads
related to: paid clinical trials multiple sclerosiswexnermedical.osu.edu has been visited by 10K+ users in the past month
262 Neil Avenue # 430, Columbus, Ohio · Directions · (614) 221-7464
dvcstem.com has been visited by 100K+ users in the past month